Assessment by Pulse Dye-densitometry Indocyanine Green (ICG) Clearance Test of Hepatic Function of Patients Before Cardiac Surgery: Its Value As a Predictor of Serious Postoperative Liver Dysfunction
Overview
Authors
Affiliations
Objective: Patients with preoperative liver dysfunction occasionally have a poor prognosis after cardiac surgery because the liver condition is aggravated. The pulse dye-densitometry indocyanine green (ICG) clearance test was used as a preoperative evaluation technique.
Design: Prospective, clinical evaluation.
Setting: Surgical intensive care unit of a national cardiovascular center.
Subjects: Twenty-seven patients with preoperative liver dysfunction were studied. They were divided into four groups depending on the cause of their liver dysfunction.
Interventions: With the patient's informed consent, a bolus of ICG, 20 mg, was injected, and the disappearance of ICG was measured noninvasively by pulse dye-densitometry.
Measurements And Main Results: The ICG retention rate at 15 minutes (ICG-R15) was calculated for the regression time. The patients were assessed in terms of ICG-R15 and the cause of liver dysfunction. The ICG-R15 values obtained for all 27 patients were 30% +/- 16% (mean +/- standard deviation). The 21 survivors had ICG-R15 values of 24% +/- 12%, whereas the 6 patients who died after surgery had significantly greater ICG-R15 values of 50% +/- 13% (p < 0.05). The mean values of ICG-R15 in patients with congestive liver, viral hepatitis accompanied by congestive liver, viral hepatitis, and cirrhosis were 34%, 23%, 13%, and 42%, respectively. The 6 of 27 patients who died after surgery had ICG-R15 values greater than 40%. Five of the seven patients with cirrhosis died.
Conclusion: These results suggest that (1) compared with Child-Pugh classification, the value of ICG-R15 provides a more accurate surgical indication; and (2) liver dysfunction from cirrhosis causes postoperative deterioration of liver function, especially when the ICG-R15 value exceeds 40%.
Yamashita A, Jang P, Bao K, Kashiwagi S, Frangioni J, Choi H Int J Mol Sci. 2025; 25(24.
PMID: 39769309 PMC: 11676035. DOI: 10.3390/ijms252413547.
Zhang H, Zeng S, Wu Y, Zhang R, Liu L, Xue Q Biomed Opt Express. 2023; 14(7):3610-3621.
PMID: 37497492 PMC: 10368033. DOI: 10.1364/BOE.493538.
Noninvasive assessment of liver function reserve with fluorescent dosimetry of indocyanine green.
Wu P, Guo L, Yu S, Zeng N, Liu Y, Yu J Biomed Opt Express. 2022; 13(4):1995-2005.
PMID: 35519254 PMC: 9045906. DOI: 10.1364/BOE.446749.
Press A, Butans M, Haider T, Weber C, Neugebauer S, Kiehntopf M Sci Rep. 2017; 7(1):15397.
PMID: 29133918 PMC: 5684357. DOI: 10.1038/s41598-017-14987-5.
Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E Liver Cancer. 2017; 6(3):204-215.
PMID: 28626732 PMC: 5473065. DOI: 10.1159/000452846.